With $75 Million from Apple Tree Partners, Initial Therapeutics ...

May 1, 2023 · About Initial Therapeutics Initial Therapeutics discovers and develops new small molecule treatments focused on known, rationally selected targets that play key roles in cancer and other serious illnesses. Initial interdicts high-value protein targets with its STOPS …

CouponFollow Extension

$75
OFF

With $75 Million From Apple Tree Partners, Initial Therapeutics ...

2 weeks from now

initialtx.com

$75
OFF

Initial Launches With $75M And A New Idea For Targeting …

2 weeks from now

May 1, 2023 · Initial launches with $75M and a new idea for targeting problematic proteins ... Dubbed Initial Therapeutics, ... Initial seeks to prevent their production by the ribosome, …

biopharmadive.com

$75
OFF

Initial Therapeutics Raises $75M In Series A Funding - FinSMEs

2 weeks from now

May 1, 2023 · Initial Therapeutics, a South San Francisco, CA-based biotechnology company, raised $75m in Series A funding. Apple Tree Partners created the company and made the …

finsmes.com

$75
OFF

Initial Therapeutics News & Press Releases | PR Newswire

2 weeks from now

May 01, 2023, 08:00 ET With $75 Million from Apple Tree Partners, Initial Therapeutics Launches to Create a New Kind of Drug Designed to Stop the Formation of Difficult-to-Drug Protein Targets

prnewswire.com

$75
OFF

Initial Therapeutics Raises $75 Million Series A Funding

2 weeks from now

May 9, 2023 · Initial Therapeutics is a biotechnology startup that is using artificial intelligence to develop new drugs faster and more efficiently than ever before. The mission of Initial …

investclub.sv

$75000000
OFF

Founder Lodge | Initial Therapeutics Raises $75,000,000 At Series A …

2 weeks from now

May 2, 2023 · Initial Therapeutics raises $75,000,000 at Series A on 2023-05-02 in Biotechnology Research, industry founded/co-founded by Jamie Cate

founderlodge.com

$75
OFF

With $75 Million From Apple Tree Partners, Initial Therapeutics ...

2 weeks from now

May 1, 2023 · Within Initial, this work has been industrialized with custom ribosomal assays scaled to ultra-large library screening using miniaturized microfluidics technology from the …

biospace.com

$75
OFF

Initial Therapeutics Raises $75M Series A Funding

2 weeks from now

May 1, 2023 · Initial Therapeutics was started With $75M from Apple Tree Partners, to Create a New Kind of Drug Designed to Stop the Formation of Difficult-to-Drug Protein Targets. Initial …

vcnewsdaily.com

$75
OFF

With $75 Million From Apple Tree Partners, Initial Therapeutics ...

2 weeks from now

May 1, 2023 · Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.

businessinsider.com

$75
OFF

Series A - Initial Therapeutics - 2023-05-01 - Crunchbase

2 weeks from now

May 1, 2023 · FinSMEs — Initial Therapeutics Raises $75M in Series A Funding . News • May 1, 2023. PR Newswire — With $75 Million from Apple Tree Partners, Initial Therapeutics …

crunchbase.com

$75
OFF

Initial Therapeutics On LinkedIn: With $75 Million From Apple Tree ...

2 weeks from now

With $75 Million from Apple Tree Partners, Initial Therapeutics Launches to Create a New Kind of Drug Designed to Stop the Formation of Difficult-to-Drug Protein Targets

linkedin.com

$75
OFF

Venture Capital News: Initial Therapeutics Raises $75M Series A …

2 weeks from now

Initial Therapeutics was started With $75M from Apple Tree Partners, to Create a New Kind of Drug Designed to Stop the Formation of Difficult-to-Drug Protein Targets. Initial Therapeutics, …

vcnewsdaily.com

$75
OFF

Initial Therapeutics: $75 Million Closed For Launching A New Drug …

2 weeks from now

May 8, 2023 · Apple Tree Partners (ATP) - a leader in life sciences venture capital - announced the launch of Initial Therapeutics, a biotechnology company created to make medicines that …

pulse2.com

$75
OFF

With $75 Million From Apple Tree Partners, Initial Therapeutics ...

2 weeks from now

On May 1, 2023 Apple Tree Partners (ATP), a leader in life sciences venture capital, reported the launch of Initial Therapeutics, a biotechnology company created to make medicines that block …

1stoncology.com

$75
OFF

New Cell Therapy Biotech Emerges From The Lab Of George Church

2 weeks from now

Sep 19, 2024 · From 'science fiction to reality': New George Church-founded biotech raises $75M for cell therapy platform By Gabrielle Masson Sep 19, 2024 6:30am

fiercebiotech.com

FAQs about With $75 Million from Apple Tree Partners, Initial Therapeutics ... Coupon?

What is initial Therapeutics?

The mission of Initial Therapeutics is to identify and develop innovative therapies that can address unmet medical needs and improve the lives of patients. The company is leveraging the latest advances in biotechnology, including genomics, proteomics, and computational biology, to discover new drug targets and develop small-molecule drugs. ...

How much money did initial Therapeutics get from Apple Tree Partners?

Initial Therapeutics has raised $75 million from venture investor Apple Tree Partners to fund its research. The new biotechnology startup aims to treat cancer and other serious illnesses by stopping cells from making disease-causing proteins. ...

Can GC Therapeutics unlock a new generation of cell therapies?

GC Therapeutics has entered gameplay with the mission of unlocking a new generation of cell therapies, uploading with $75 million for its “plug-and-play” tech developed in the lab of—and with cells from—George Church, Ph.D. “George donated his skin cells, which were reprogrammed into the stem cells that were used. ...

Could Cambridge Biotech be the first iPSC-based cell therapy company?

The Cambridge, Massachusetts-based biotech could be the first iPSC-based cell therapy company to pursue multiple cell products from one starting point using a similar manufacturing strategy for more accelerated development. ...

What does GC Therapeutics mean?

Of course, GC Therapeutics could also mean gene and cell therapeutics, or the letters of DNA.” The biotech has capped off a $65 million series A financing led by Cormorant Asset Management with participation from Mubadala Capital and Andreessen Horowitz (a16z) Bio + Health, among others. ...